Casi Pharmaceuticals Share Price (NASDAQ: CASI)
$2.35
Last updated on
Check the interactive Casi Pharmaceuticals Stock chart to analyse performance
Casi Pharmaceuticals stock performance
as on August 30, 2025 at 1:29 am IST
- Today's Low:$2.33Today's High:$2.36
0.85%
Downside
Day's Volatility :1.27%
Upside
0.42%
- 52 Weeks Low:$1.0952 Weeks High:$7.67
53.58%
Downside
52 Weeks Volatility :85.78%
Upside
69.36%
Casi Pharmaceuticals Stock Returns
Casi Pharmaceuticals Inc Key Stats
Check Casi Pharmaceuticals key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Casi Pharmaceuticals Stock including INR - Dollar returns
The Casi Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Casi Pharmaceuticals investment value today
Current value as on today
₹40,944
Returns
Returns from Casi Pharmaceuticals Stock
Dollar Returns*
₹5,284 (+5.28%)
Indian investors sentiment towards Casi Pharmaceuticals Stock
Global Institutional Holdings in Casi Pharmaceuticals Inc
Name
Holdings %
Analyst Recommendation on Casi Pharmaceuticals Stock
Buy
85%Buy
14%Hold
0%Sell
Based on 7 Wall street analysts offering stock ratings for Casi Pharmaceuticals(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Casi Pharmaceuticals Share Price Target
What analysts predicted
Upside of 70.21%
Target:
$4.00
Current:
$2.35
Casi Pharmaceuticals share price target is $4.00, a slight Upside of 70.21% compared to current price of $2.35 as per analysts' prediction.
Casi Pharmaceuticals Stock Insights
Price Movement
In the last 1 month, CASI stock has moved up by 54.6%Decreasing Revenue
Revenue is down for the last 2 quarters, 13.35M → 6.24M (in $), with an average decrease of 53.3% per quarterIncreasing Net Profit
Netprofit is up for the last 2 quarters, -14.37M → -10.75M (in $), with an average increase of 33.7% per quarterCASI vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 134.2%CASI vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 149.3%Price to Sales
ForCASI every $1 of sales, investors are willing to pay $1.2, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.5 for every $1 of sales.
Casi Pharmaceuticals Inc Financials
Casi Pharmaceuticals Technicals Summary
Sell
Neutral
Buy
Casi Pharmaceuticals is currently in a neutral trading position according to technical analysis indicators.
Casi Pharmaceuticals Inc Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| 80.77% | 3.52% | -63.85% | -37.83% | -85.76% |
 | 6.48% | -15.2% | -50.31% | -3.3% | -2.01% |
 | 1.77% | 24.81% | 62.78% | 79.11% | 29.69% |
 | -14.45% | -19.13% | -17.84% | 34.68% | 41.87% |
 | 13.79% | 83.28% | 75.87% | 111.28% | 242.25% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| NA | NA | 0.0 | -2.07 | -10.94 | -0.51 | NA | -0.52 |
| 14.6 | 14.6 | 1.2 | 39.42 | 0.15 | 0.07 | 0.0 | 287.55 |
| NA | NA | NA | 2.73 | -0.05 | -0.01 | NA | 34.32 |
| 27.86 | 27.86 | 0.58 | 18.06 | 0.23 | 0.13 | NA | 67.02 |
| NA | NA | -0.49 | 3.92 | -2.58 | -0.03 | NA | 1.91 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Buy | $37.8M | -85.76% | NA | -129.05% |
| Buy | $61.4B | -2.01% | 14.6 | 31.37% |
| NA | $36.5B | 29.69% | NA | -3.89% |
| Buy | $100.5B | 41.87% | 27.86 | 31.86% |
| Buy | $59.5B | 242.25% | NA | -12.96% |
About Casi Pharmaceuticals Inc
Key Management of Casi Pharmaceuticals Inc
Important FAQs about investing in CASI Stock from India :
What is Casi Pharmaceuticals share price today?
Casi Pharmaceuticals share price today is $2.35 as on at the close of the market. Casi Pharmaceuticals share today touched a day high of $2.36 and a low of $2.33.
What is the 52 week high and 52 week low for Casi Pharmaceuticals share?
Casi Pharmaceuticals share touched a 52 week high of $7.67 and a 52 week low of $1.09. Casi Pharmaceuticals stock price today i.e. is closed at $2.35, lower by 69.36% versus the 52 week high.
How to invest in Casi Pharmaceuticals Stock (CASI) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Casi Pharmaceuticals on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Casi Pharmaceuticals Shares that will get you 0.6383 shares as per Casi Pharmaceuticals share price of $2.35 per share as on August 30, 2025 at 1:29 am IST.
What is the minimum amount required to buy Casi Pharmaceuticals Stock (CASI) from India?
Indian investors can start investing in Casi Pharmaceuticals (CASI) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Casi Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on August 31, 2025).
Based on Casi Pharmaceuticals share’s latest price of $2.35 as on August 30, 2025 at 1:29 am IST, you will get 4.2553 shares of Casi Pharmaceuticals. Learn more about
fractional shares .
What are the returns that Casi Pharmaceuticals has given to Indian investors in the last 5 years?
Casi Pharmaceuticals stock has given -85.76% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?
Discover More
- Webs Defined Volatility Xle
$24.99
-0.04%
- United States 12 Month Natur
$7.81
+1.83%
- F/m U S T Inl-p S (tips) Etf
$50.14
+0.06%
- Pgim Jennison Focused Growth Etf
$105.89
-1.37%
Hitek Global Inc$1.49
+1.36%
Vaneck Vectors Preferred Secs Ex Finls Etf$17.68
-0.73%
Marker Therapeutics Inc$0.93
+3.33%
Grupo Aval Acciones Y Valores S.a.$3.33
-0.89%